Introducing Golden Connections, the thriving society of UB grads who have been getting and giving some of the best UB parties ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Could this work to prevent blindness and eventually turn back the clock in other organs too?

More years of mobility and independence, and fewer prolonged periods of illness later in life, is certainly alluring, but is ...

As Dubai continues to strengthen its position as a global hub for longevity, health innovation and advanced medicine, Next ...

A new book by New York Times reporters Maggie Haberman and Jonathan Swan claims JD Vance suggested India and Saudi Arabia as possible peacekeepers in Ukraine during an Oval Office meeting. According ...

What sets Kurzweil apart from many futurists is his track record. Over several decades, he correctly anticipated the rise of the internet as a dominant global communications platform, the emergence of ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in the human eye. The study, called ER-100, uses a gene therapy vector to ...

Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...